CorporateInvestorsMay 08, 2024

Wolters Kluwer 2024 Annual General Meeting of Shareholders adopts all resolutions

Wolters Kluwer (Euronext: WKL), a global leader of professional information, software solutions, and services, announces that all resolutions were adopted as proposed at today’s Annual General Meeting of Shareholders (AGM).

Composition Supervisory Board

David Sides has been appointed as a member of the Supervisory Board of Wolters Kluwer for a term of four years. Mr. Sides is President and CEO of NextGen Healthcare, a leading provider of innovative technology solutions focused on ambulatory care. Sophie Vandebroek has been reappointed as a member of the Supervisory Board for a second term of four years, and Jack de Kreij has been reappointed for a two-year term. Jeanette Horan, whose second four-year term expired after the AGM, regretfully has informed Wolters Kluwer that she is not available for reappointment. Heleen Kersten will succeed her as co-Chair of the Selection and Remuneration Committee. The Supervisory Board is conducting a search for a new candidate to replace Ms. Horan, to bring the number in line with the profile.

2023 Financial Statements and Dividend

The AGM adopted the 2023 financial statements as included in the 2023 Annual Report and approved a total dividend of €2.08 per ordinary share, resulting in a final dividend of €1.36 per ordinary share, payable in June 2024. The cash dividend will be paid net of 15% dividend withholding tax where applicable.

Remuneration

The Remuneration Report was approved by shareholders in an advisory vote. The Supervisory Board remuneration policy and the proposal to amend the Supervisory Board remuneration were adopted.

Other AGM resolutions

All other AGM voting items on the agenda were adopted. This includes the resolutions to release the members of the Executive Board and the Supervisory Board from liability for the exercise of their respective duties, and the extension of the authority of the Executive Board to issue shares, to acquire shares in the company, and to cancel shares, as well as an amendment of the Articles of Association.

Shareholders represented

Wolters Kluwer shareholders were represented in person, by proxy voting, or by voting instruction, representing a total of 78.11% of the total issued share capital entitled to vote.

Detailed voting results by agenda item will be available on our at www.wolterskluwer.com/agm shortly.

Financial Calendar

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Forward-looking Statements and Other Important Legal Information

This report contains forward-looking statements. These statements may be identified by words such as “expect”, “should”, “could”, “shall” and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; conditions created by global pandemics, such as COVID-19; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer’s businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Elements of this press release contain or may contain inside information about Wolters Kluwer within the meaning of Article 7(1) of the Market Abuse Regulation (596/2014/EU).

Trademarks referenced are owned by Wolters Kluwer N.V. and its subsidiaries and may be registered in various countries.

Explore related topics

Back To Top